Technology | Advanced Visualization | February 27, 2019

Philips Introduces IntelliSpace Portal 11 at ECR 2019

Latest release of Philips advanced visualization platform builds on intelligent clinical applications, hospital network connectivity and patient data security

Philips Introduces IntelliSpace Portal 11 at ECR 2019

February 27, 2019 — Philips announced the launch of IntelliSpace Portal 11, the latest release of the company’s comprehensive, advanced visualization and quantification software. Launching at the 2019 European Congress of Radiology (ECR), Feb. 27-March 3 in Vienna, Austria, the new version further extends the clinical innovation of the portal, with enhancements to improve workflow efficiencies, bridging secure data sharing between systems within the hospital network to address the security and privacy needs of customers globally.

Philips IntelliSpace Portal is an advanced visualization and analysis software solution designed to support diagnostic process, follow-up and communication across clinical domains and modalities, through a connected and secure workflow. The solution is a multimodality and multivendor comprehensive suite of advanced visualization solutions for radiology. It can scale to fit large scale enterprises, helping to maximize resources by leveraging analytical tools.

Philips IntelliSpace Portal 11 offers a seamless integrated portfolio of clinically rich applications for neurology, oncology and cardiology domains. The new version is focused on enhancing clinical workflow and automation via adaptive intelligence (aka artificial intelligence, or AI) functionalities, combining clinical data from multimodalities across the health continuum. The latest iteration also includes a new integrated Nuclear Medicine Viewer by Mirada Medical designed to support clinical challenges and productivity, with a dedicated optimized workflow for quantitative patient follow-up.

IntelliSpace Portal 11 introduces new zero-footprint viewer capabilities running directly through a web browser to provide anywhere access to advanced visualization data review during multi-disciplinary meetings inside or outside the hospital. Users can consult and share findings online with real-time peer to peer interaction. The viewer also offers scalability from a single department to an enterprise-wide solution. Philips noted that the zero-footprint viewer is not intended for diagnostic review.

Supporting patient data confidentiality, integrity and availability are part of the IntelliSpace Portal 11 security policy. The solution can be tailored to the customer environment, allowing flexible settings for patient and role-based access controls, designed to protect sensitive data from unauthorized access.

For more information: www.usa.philips.com/healthcare

Related Content

A World Health Organization (WHO) rapid advice guide on the use of chest imaging in the diagnosis and management of COVID-19 was published in the journal Radiology.

Getty Images

News | Coronavirus (COVID-19) | July 30, 2020
July 30, 2020 — A World Health Organization (WHO) rapid advice gui
Candelis, Inc., a leading provider of innovative and cost-effective enterprise healthcare solutions, and VasoTechnololgy, a subsidiary of the Vaso Corporation, announced an agreement to distribute Candelis' suite of image management PACS solutions and cloud services, including ImageGrid, ImageGrid Mini PACS and ASTRA Cloud.
News | Enterprise Imaging | July 29, 2020
July 29, 2020 — Candelis, Inc., a leading provider of innovative and cost-effective enterprise healthcare solutions,
 The Radiological Society of North America (RSNA) has been awarded a $750,000 grant by the Department of Energy’s National Nuclear Security Administration (NNSA) to develop a Global Learning Center (GLC) in Sub-Saharan Africa. The grant will help address the growing need in Sub-Saharan Africa for training in radiology.
News | Radiology Education | July 28, 2020
July 28, 2020 — The Radiological Society of North America (RSNA)
Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

News | Prostate Cancer | July 28, 2020
July 28, 2020 — A study published in 
Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo, which has already received a CE mark. Zebra Medical’s algorithm empowers breast radiologists by prioritizing and identifying suspicious mammograms, providing a safety net for radiologists. The suspicious mammograms are identified faster and read earlier than the current “first-in first-out” standard of care. 
News | Breast Imaging | July 27, 2020
July 26, 2020 —  Zebra Medical Vision announced its sixth FDA 510
Clearing medical device cybersecurity requirements from DoD delivers even more safety assurance for customers
News | Cybersecurity | July 23, 2020
July 23, 2020 — Carestream Health’s ImageView software has received the Risk Management Framework Authority to Operat